Home > Drug Search >
  • company_query: AROG Pharmaceuticals
  •   > 
Drug Filter
Category:
chemistry (24) biology (1)
Status:
NDA Filing (1) Phase Ⅲ (4) Phase Ⅱ (14) Phase Ⅰ (6)
Clinical Stage:
Pending (4) Active (11) Discontinued (10)
Indication:
Acute myeloid Leukemia (AML) (2) Allergic rhinitis (AR) (1) Alzheimer's disease (AD) (2) Asthma (3) Chronic lymphocytic leukemia (CLL) (1) Deep vein thrombosis (DVT) (1) Dry eye disease (1) Duchenne muscular dystrophy (DMD) (1) Transplant rejection (1) Gastrointestinal stromal tumors (GISTs) (1) Generalised anxiety disorder (GAD) (1) Melanoma (1) Metastatic breast cancer (1) Multiple sclerosis (MS) (1) Non small cell lung cancer (NSCLC) (1) Non-alcoholic fatty liver disease (NAFLD) (1) Pulmonary embolism (1) Solid tumours (5) Stroke and systemic embolism (1) Systemic lupus erythematosus (1) Type 2 diabetes (2) Urinary frequency (1) Urinary incontinence (1) Venous thromboembolism (VTE) (1) Head and neck cancer (1) Neuroblastoma (1) Essential tremor (1) Intermittent claudication (1) Thrombosis (1) Interstitial cystitis (1) Discoid lupus erythematosus (1) Immune thrombocytopenic purpura (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top